Intestinal microflora of human infants and current trends for its nutritional modulation

British Journal of Nutrition

Volumn 87, Issue 5, 2002, Pages 405-420

  Mountzouris, Konstantinos C ^a,b   McCartney, Anne L ^a   Gibson, Glenn R ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b Thrakomakedones ^*  (Greece)

Author keywords

Colonic microflora; Dietary modulation; Functional foods; Human infants

Indexed keywords

ALPHA GLUCOSIDASE; AMYLASE; ANTIBIOTIC AGENT; BETA CASEIN; BETA CASOMORPHINE; BETA LACTOGLOBULIN; CARBOHYDRATE; CASEIN; FRUCTOSE OLIGOSACCHARIDE; LACTASE; LACTOFERRIN; LACTULOSE; NUCLEOTIDE; OLIGOSACCHARIDE; PEPSIN A; PEPTIDE HYDROLASE; PHLORIZIN; PREBIOTIC AGENT; PROBIOTIC AGENT; PROTEIN; PROTEINASE; SHORT CHAIN FATTY ACID; SUCRASE ISOMALTASE; TREHALASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIUM; BOTTLE FEEDING; BREAST FEEDING; BREAST MILK; DIARRHEA; DIET; DIET SUPPLEMENTATION; FECES ANALYSIS; FERMENTATION; FOOD COMPOSITION; GASTROINTESTINAL TRACT; GENETIC ANALYSIS; HUMAN; INCIDENCE; INFANCY; INFECTION; INTESTINE FLORA; METABOLISM; NONHUMAN; NUTRITION; REVIEW;

BACTERIA (MICROORGANISMS); MICROBIOTA;

EID: 0036265580     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN2002563     Document Type: Review

References (145)

1. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations
2. Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic and environmental studies in microbiology
3. In situ hybridisation
4. Effects of lactulose and lactitol on colonic microflora and enzymatic activity
5. Diet and faecal flora in the newborn: Nucleotides
6. Development of the fecal anaerobic microflora after Caesarean section and treatment with antibiotics in newborn infants
7. Transient colonisation of the gut of newborn infants by orally administered bifidobacteria and lactobacilli
8. The intestinal microflora of infants: Composition of faecal flora in breast-fed and bottle-fed infants
9. The indigenous gastrointestinal microflora
10. The intestinal microflora during the first weeks of life
11. Modulation of Clostridium perfringens intestinal colonisation in infants delivered by Caesarean section
12. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans
13. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans
14. Fermentation of various dietary fiber sources by human fecal bacteria
15. Nucleotides in infant nutrition
16. Digestion of human milk oligosaccharides by healthy infants evaluated by the lactulose hydrogen breath test
17. Aerobic and anaerobic bacterial flora of the maternal cervix and newborn gastric fluid and conjunctiva: A prospective study
18. The effect of "humanized" milks and supplemented breast feeding on the faecal flora of infants
19. Bifidobacterial supplementation reduces the incidence of necrotising enterocolitis in a neonatal rat model
20. Influences of microbiota on intestinal immune system development
21. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract
22. Starch digestion in infancy
23. Probiotics, prebiotics, and synbiotics: Approaches for modulating the microbial ecology of the gut
24. Changes in carbohydrate composition in human milk over 4 months of lactation
25. Nucleotides
26. Workshop: Physiology and tolerance of LDCs
27. The control and consequences of bacterial fermentation in the human colon
28. Nutrition and the immune system of the gut
29. Evolution of infant nutrition
30. Energy utilisation and growth in breast-fed and formula-fed infants measured prospectively during the first year of life
31. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract
32. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes
33. Probiotics in man and animals
34. Expression of functional immunomodulatory and anti-inflammatory factors in human milk
35. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
36. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics
37. Effects of the addition of nucleotides to an adapted milk formula on the microbial pattern of feces in at term newborn infants
38. Human milk oligosaccharides are minimally digested in vitro
39. Spectrum of immunomodulating agents in human milk
40. Fecal microflora in healthy infants born by different methods of delivery: Permanent changes in intestinal flora after cesarean delivery
41. Development of intestinal bacterial enzymes in infants - Relationship to mode of delivery and type of feeding
42. Disaccharide digestion and maldigestion
43. Undialyzable factors for Lactobacillus bifidus var pennsylvanicus: Protective effects of sialic acid bound to glycoproteins and oligosaccharides against bacterial degradation
44. Bifidus factor I. A variant of Lactobacillus bifidus requiring a special growth factor
45. Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate
46. A reassessment of the microbial flora of the female genital tract, with special reference to the occurrence of Bacteroides species
47. Lingual lipase and fat digestion in the neonatal period
48. Introduction: Should infant formulas be supplemented with bioactive components and conditionally essential nutrients present in human milk
49. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods
50. Comparison of media for the detection of bifidobacteria, lactobacilli and total anaerobes from faecal samples
51. The gut microflora of the developing infant: Microbiology and metabolism
52. The importance of alpha-lactalbumin in infant nutrition
53. Bile-salt-stimulated lipase of human milk and lipid digestion in the neonatal period
54. Survival of human pancreatic enzymes during small bowel transit: Effect of nutrients, bile acids, and enzymes
55. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children
56. Infant formula and follow-on formula
57. Effects of isomaltooligosaccharides with different degrees of polymerisation on human fecal bifidobacteria
58. Effects of composition of infant formulas on the intestinal microflora of infants
59. In vivo lactose digestion in preterm infants
60. Bacteriocins of lactic acid bacteria: Their potential as food biopreservative
61. The ability of probiotic bacteria to bind to human intestinal mucus
62. Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants
63. Dose-response test of isomaltooligosaccharides for increasing fecal bifidobacteria
64. Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces
65. Complex oligosaccharides in infant nutrition
66. Biological functions of oligosaccharides in human milk
67. Antibacterial and immunostimulating casein-derived substances from milk: Casecidin, isracidin peptides
68. Infant nutrition part 1: Preweaning (0-4 months)
69. Quantitative in situ hybridisation of Bifidobacterium spp. with genus-specific 16S-rRNA-targeted probes and its application in fecal samples
70. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants
71. Implantation and in vivo antagonistic effects of antibiotic-susceptible Escherichia coli strains administered to premature newborns
72. The ontogeny of the small intestinal epithelium
73. Digestibility of starches and modified food starches
74. Hydrolysis of proteins and proteolytic activity
75. Digestion and absorption of carbohydrates - From molecules and membranes to humans
76. Immunonutrition: The pediatric experience
77. Delayed complete functional lactase sufficiency in breast-fed infants
78. Characterisation of carbohydrate fermentation in feces of formula-fed and breast-fed infants
79. Tolerance of low-digestible carbohydrates: A general view
80. Breast-feeding lowers the frequency and duration of acute respiratory infection and diarrhea in infants under six months of age
81. The composition of the faecal microflora of breastfed and bottle fed infants from birth to eight weeks
82. Contribution of the microflora on the proteolysis in the human large intestine
83. The human colonic microbiota
84. Validation of a three-stage continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon
85. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression
86. Developmental microbial ecology on the neonatal gastrointestinal tract
87. Tolerance to low-digestible carbohydrates: Symptomatology and methods
88. Fecal microflora in healthy persons in a preindustrial region
89. Bifidobacterium, Bacteroides, and Clostridium spp. in fecal samples from breast-fed and bottle-fed infants with and without iron supplement
90. Production of short chain fatty acids by the intestinal microflora during the first 2 years of human life
91. Enteral feeding of premature infants with Lactobacillus GG
92. Application of 16S rRNA gene PCR to study bowel flora of preterm infants with and without necrotising enterocolitis
93. Some current concepts in intestinal bacteriology
94. Modelling of oligodextran production in an ultra-filtration stirred-cell membrane reactor
95. Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction
96. Neutral oligosaccharide content of preterm human milk
97. Do the binding properties of oligosaccharides in milk protect human infants from gastrointestinal bacteria?
98. The establishment of some microflora associated biochemical characteristics in feces from children during the first years of life
99. In vitro fermentability of dextran oligodextran and maltodextrin by human gut bacteria
100. Methods of analysis of the intestinal microflora
101. Adhesion of probiotic micro-organisms to intestinal mucus
102. Inhibition of pathogen adhesion by β-lactoglobulin
103. Growth factors and antimicrobial factors of bovine colostrum
104. In vitro fermentation of carbohydrate by breast and formula fed infants
105. Colonic fermentation capacity in vitro: Development during weaning in breast-fed infants is slower for complex carbohydrates than for sugars
106. Isolation and identification of three bactericidal domains in the bovine alpha-lactalbumin molecule
107. Glycoproteins of the human milk fat globule in the protection of the breast fed infant against infections
108. Ability of lactoferrin to promote the growth of Bifidobacterium spp. in vitro is independent of receptor binding capacity iron saturation level
109. The effect of α-lactalbumin and β-lactoglobulin hydrolysates on the metabolic activity of Escherichia coli JM 103
110. Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea
111. Lactase; Origin, gene expression, localisation, and function
112. Bacterial flora of breast-fed infants
113. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
114. Potent bactericidal activity of bovine lactoferrin hydrolysate produced by heat treatment at acidic pH
115. Recent progress on research and applications of non-digestible galacto-oligosaccharides
116. Functional food science and gastrointestinal physiology and function
117. Clinical applications of probiotic bacteria
118. Lactulose, lactic acid bacteria, intestinal microbiology and mucosal protection
119. Milk-borne bioactive peptides
120. Nucleic acid probes
121. Nucleosides and nucleotides: Natural bioactive substances in milk and colostrum
122. Potential ligands for cell adhesion molecules in human milk
123. Fecal excretion in infants
124. Faecal short-chain fatty acids in breast fed and bottle-fed infants
125. An assessment of three selective media for bifidobacteria in faeces
126. Effect of feeding on infants' faecal flora
127. Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources
128. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life
129. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut
130. Bacteriocins of Gram-positive bacteria
131. Nutriology of bifidobacteria
132. Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora
133. Plasmid profiling of members of the family Enterobacteriaceae, lactobacilli and bifidobacteria to study the transmission of bacteria from mother to infant
134. Congenital sucrase-isomaltase deficiency
135. Immunonutrition: The role of carbohydrates
136. In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence
137. Rationale for the luminal provision of butyrate in intestinal diseases
138. PCR detection and quantification of predominant anaerobic bacteria in human and animal fecal samples
139. Effects of the in vivo fermentation of oligofructose and inulin by bacteria growing in the human large intestine
140. Protein nutrition, fecal flora and iron-metabolism - The role of milk-based formulae
141. Characterisation and antimicrobial spectrum of bifidocin B, a bacteriocin produced by Bifidobacterium bifidum NCFB 1454
142. Development of the normal intestinal flora and its clinical significance in infants and children
143. On the intestinal flora of bottle-fed infants
144. S2 derived peptide exhibits antibacterial activity